研究疾病:
|
急性期带状疱疹
|
研究疾病代码:
|
|
Target disease:
|
Acute Herpes Zoster
|
Target disease code:
|
研究类型:
Study type:
|
干预性研究
Interventional study
|
研究设计:
Study design:
|
随机平行对照
randomized controlled trial(parallel group design)
|
研究所处阶段:
Study phase:
|
探索性研究/预试验
Pilot clinical trial
|
研究目的:
|
评价火针联合西药治疗急性期带状疱疹(肝经郁热型)的近、远期疗效
|
Objectives of Study:
|
To evaluate the short-term and long-term efficacy of fire acupuncture combined with western medicine in the treatment of acute herpes zoster (liver channel heat stasis type)
|
药物成份或治疗方案详述:
|
招募60例急性带状疱疹(肝经郁热型)患者随机分为火针组、普通针刺组、基础组。火针组在西药的基础上接受普通针刺和火针治疗,普通针刺组在西药的基础上接受普通针刺治疗,基础组仅接受西药治疗。以视觉模拟评分(VAS)、止疱时间、结痂时间、脱痂时间、神经痛发生率、后遗神经痛发生率、生活质量量表(SF-36)、汉密尔顿焦虑量表(HAMA)、汉密尔顿抑郁量表(HAMD)、匹兹堡睡眠质量指数(PSQI)、带状疱疹综合疗效评分,分别观察各组在治疗结束时(4周)、随访时(治疗结束后3个月、6个月)的症状改善情况,以评价针灸结合西药治疗对该病的疗效。
|
Description for medicine or protocol of treatment in detail:
|
A total of 60 patients with acute herpes zoster were randomly divided into fire acupuncture group, ordinary acupuncture group and basic acupuncture group. The fire acupuncture group received ordinary acupuncture and fire acupuncture on the basis of western medicine, the ordinary acupuncture group received ordinary acupuncture on the basis of western medicine, and the basic group only received western medicine. Visual analogue scale (VAS), time to stop blisters, time to scab, time to exscab, incidence of neuralgia, incidence of residual neuralgia, Quality of life scale (SF-36), Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), Pittsburgh Sleep Quality Index (PSQI), comprehensive efficacy score of herpes zoster. The symptom improvement of each group was observed at the end of treatment (4 weeks) and follow-up (3 months and 6 months after the end of treatment), so as to evaluate the efficacy of acupuncture combined with western medicine in treating the disease.
|
纳入标准:
|
(1)符合带状疱疹上述西医诊断标准及中医诊断标准者;
(2)年龄在18-75岁之间,性别不限;
(3)出现疱疹和疼痛在1-7天内,未经过抗病毒、止痛、营养神经、针灸等中西医治疗者;
(4)已签知情同意书,了解并接受本研究治疗方案者。
|
Inclusion criteria
|
(1) Those who meet the above-mentioned Western and Chinese medical diagnostic criteria for herpes zoster;
(2) Age between 18 and 75, no gender limitation;
(3) Patients with herpes and pain occurring within 1-7 days without receiving antiviral, analgesic, nerve nutrition, acupuncture and other traditional Chinese and Western medicine treatment;
(4) Those who have signed the informed consent to understand and accept the treatment plan in this study.
|
排除标准:
|
(1)属于无疹型带状疱疹、顿挫型带状疱疹、播散性带状疱疹、眼带状疱疹、耳带状疱疹、脑膜带状疱疹、大疱性、出血性、坏疽性等表现的带状疱疹者;
(2)近1个月接受过皮质类固醇激素或免疫抑制剂治疗者;
(3)妊娠或哺乳期妇女;
(4)过敏体质者及对多种药物过敏者;
(5)瘢痕体质者;
(6)患有严重的心脑血管疾病,肝、肾、造血系统等原发性疾病或全身器官功能衰竭者,糖尿病、血友病、恶性肿瘤、精神病患者,凝血功能异常的患者;
(7)病情危重,难以评价治疗效果的患者。
|
Exclusion criteria:
|
(1) Patients with herpes zoster without rash, herpes zoster with stenting, herpes zoster with disseminated, herpes zoster with eye, herpes zoster with ear, herpes zoster with meninges, herpes zoster with bullosa, hemorrhagic, gangrene and so on;
(2) Those who have received corticosteroid or immunosuppressive therapy in the past 1 month;
(3) Pregnant or lactating women;
(4) People with allergic constitution and allergic to a variety of drugs;
(5) scar body;
(6) Patients suffering from serious cardiovascular and cerebrovascular diseases, liver, kidney, hematopoietic system and other primary diseases or systemic organ function failure, diabetes, hemophilia, malignant tumor, mental illness, and patients with abnormal coagulation function;
(7) Patients in critical condition who are difficult to evaluate the treatment effect.
|
研究实施时间:
Study execute time:
|
从From
2022-09-30
至To
2024-09-30
|
征募观察对象时间:
Recruiting time:
|
从From
2022-10-01
至To
2023-10-01
|